(Q40396910)

20 September 2017

Bone metabolism in renal transplant patients treated with cyclosporine or sirolimus (English)

1 reference

20 September 2017

1 reference

Josep M Campistol

1

1 reference

20 September 2017

David W Holt

2

1 reference

20 September 2017

Solomon Epstein

3

1 reference

20 September 2017

Martine Gioud-Paquet

4

1 reference

20 September 2017

Karine Rutault

5

1 reference

20 September 2017

James T Burke

6

1 reference

20 September 2017

Sirolimus European Renal Transplant Study Group*

7

1 reference

20 September 2017

language of work or name

1 reference

1 September 2005

1 reference

20 September 2017

Transplant International

1 reference

20 September 2017

18

1 reference

20 September 2017

1028-1035

1 reference

20 September 2017

9

1 reference

Mechanism of transplantation-associated bone loss

20 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00163.X

Osteoporosis after renal transplantation: single center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00163.X

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00163.X

Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00163.X

Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00163.X

Rapamycin in transplantation: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00163.X

Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00163.X

Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00163.X

Biochemical markers of bone metabolism: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00163.X

Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00163.X

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00163.X

10.1111/J.1432-2277.2005.00163.X

21 January 2018

Identifiers

DOI

1 reference

release_f7ue562gjbgvxfxxvisntsx5xu

20 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/f7ue562gjbgvxfxxvisntsx5xu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference